IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 144 filers reported holding IMMUNOVANT INC in Q1 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $42,325,512 | +16.1% | 1,102,514 | -42.6% | 2.01% | +44.0% |
| Q2 2023 | $36,444,253 | +78.4% | 1,921,152 | +45.9% | 1.40% | +57.9% |
| Q1 2023 | $20,427,151 | +5.8% | 1,317,031 | +21.0% | 0.89% | +12.2% |
| Q4 2022 | $19,314,325 | +353.8% | 1,088,131 | +799.7% | 0.79% | +912.8% |
| Q3 2020 | $4,256,000 | -70.9% | 120,940 | -79.8% | 0.08% | -71.1% |
| Q2 2020 | $14,610,000 | – | 600,000 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 7,510,412 | $264,291,000 | 6.36% |
| Ghost Tree Capital, LLC | 525,000 | $18,475,000 | 5.34% |
| Pinz Capital Management, LP | 199,100 | $7,006,000 | 2.56% |
| ACUTA CAPITAL PARTNERS, LLC | 250,000 | $8,798,000 | 2.39% |
| BVF INC/IL | 1,198,427 | $42,173,000 | 2.30% |
| Cormorant Asset Management, LP | 1,637,951 | $57,639,000 | 2.22% |
| Vivo Capital, LLC | 1,042,460 | $36,684,000 | 2.12% |
| Parkman Healthcare Partners LLC | 150,151 | $5,284,000 | 1.40% |
| MANGROVE PARTNERS IM, LLC | 230,307 | $8,105,000 | 1.02% |
| Ikarian Capital, LLC | 321,887 | $11,328,000 | 0.82% |